In contrast, there was no statistically significant difference in TIM-3 expression between patients with CLL and HVs (226.9 vs. 183.1; p = 0.7251) (Figure 1d). This evidence concerns the gene HAVCR2 and B-cell chronic lymphocytic leukemia.